These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 17413613)

  • 21. Risk factors for fibrosis progression in HIV/HCV coinfected patients from a retrospective analysis of liver biopsies in 1985-2002.
    Schiavini M; Angeli E; Mainini A; Zerbi P; Duca PG; Gubertini G; Vago L; Fociani P; Giorgi R; Cargnel A
    HIV Med; 2006 Jul; 7(5):331-7. PubMed ID: 16945079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection.
    Petta S; Cammà C; Di Marco V; Alessi N; Cabibi D; Caldarella R; Licata A; Massenti F; Tarantino G; Marchesini G; Craxì A
    Am J Gastroenterol; 2008 May; 103(5):1136-44. PubMed ID: 18477344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Should trichrome stain be used on all post-liver transplant biopsies with hepatitis C virus infection to estimate the fibrosis score?
    Tretheway D; Jain A; LaPoint R; Sharma R; Orloff M; Milot P; Bozorgzadeh A; Ryan C
    Liver Transpl; 2008 May; 14(5):695-700. PubMed ID: 18324621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ethnicity and body mass index are associated with hepatitis C presentation and progression.
    Kallwitz ER; Layden-Almer J; Dhamija M; Berkes J; Guzman G; Lepe R; Cotler SJ; Layden TJ
    Clin Gastroenterol Hepatol; 2010 Jan; 8(1):72-8. PubMed ID: 19686868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of fibrosis progression in untreated irish women with chronic hepatitis C contracted from immunoglobulin anti-D.
    Levine RA; Sanderson SO; Ploutz-Snyder R; Murray F; Kay E; Hegarty J; Nolan N; Kelleher D; McDonald G; O'Keane JC; Crowe J
    Clin Gastroenterol Hepatol; 2006 Oct; 4(10):1271-7. PubMed ID: 16901770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of fibrosis in HCV-infected liver transplant recipients with a simple noninvasive index.
    Benlloch S; Berenguer M; Prieto M; Rayón JM; Aguilera V; Berenguer J
    Liver Transpl; 2005 Apr; 11(4):456-62. PubMed ID: 15776403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of FIBROSpect II with histologic and morphometric evaluation of liver fibrosis in chronic hepatitis C.
    Patel K; Nelson DR; Rockey DC; Afdhal NH; Smith KM; Oh E; Hettinger K; Vallée M; Dev A; Smith-Riggs M; McHutchison JG
    Clin Gastroenterol Hepatol; 2008 Feb; 6(2):242-7. PubMed ID: 18187364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive clinical assessment improves the accuracy of predicting cirrhosis in chronic hepatitis C.
    Gordon A; Bailey MJ; Gibson PR; Roberts SK
    J Gastroenterol Hepatol; 2005 Jun; 20(6):825-32. PubMed ID: 15946128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Smoking is associated with steatosis and severe fibrosis in chronic hepatitis C but not B.
    Tsochatzis E; Papatheodoridis GV; Manolakopoulos S; Tiniakos DG; Manesis EK; Archimandritis AJ
    Scand J Gastroenterol; 2009; 44(6):752-9. PubMed ID: 19296398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progression of fibrosis in chronic hepatitis C.
    Ghany MG; Kleiner DE; Alter H; Doo E; Khokar F; Promrat K; Herion D; Park Y; Liang TJ; Hoofnagle JH
    Gastroenterology; 2003 Jan; 124(1):97-104. PubMed ID: 12512034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of steatosis and inflammation on liver fibrosis in chronic hepatitis C.
    Nieminen U; Arkkila PE; Kärkkäinen P; Färkkilä MA
    Liver Int; 2009 Feb; 29(2):153-8. PubMed ID: 18482270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting progressive hepatic fibrosis stage on subsequent liver biopsy in chronic hepatitis C virus infection.
    Collier JD; Woodall T; Wight DG; Shore S; Gimson AE; Alexander GJ
    J Viral Hepat; 2005 Jan; 12(1):74-80. PubMed ID: 15655051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical presentation of chronic hepatitis C in patients with end-stage renal disease and on hemodialysis versus those with normal renal function.
    Hu KQ; Lee SM; Hu SX; Xia VW; Hillebrand DJ; Kyulo NL
    Am J Gastroenterol; 2005 Sep; 100(9):2010-8. PubMed ID: 16128946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of elevated alpha-fetoprotein (AFP) in chronic hepatitis C without hepatocellular carcinoma.
    Chen CH; Lin ST; Kuo CL; Nien CK
    Hepatogastroenterology; 2008; 55(85):1423-7. PubMed ID: 18795704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Chronic hepatitis C virus infection and associated liver disease among the inmates of a Spanish prison].
    Murcia J; Portilla J; Bedia M; Palazón JM; Sánchez-Payá J; Saiz de la Hoya P; Payá A; Boix V; Merino E; Reus S
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):206-12. PubMed ID: 19246126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 8-Hydroxy-2'-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.
    Chuma M; Hige S; Nakanishi M; Ogawa K; Natsuizaka M; Yamamoto Y; Asaka M
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1431-6. PubMed ID: 18854000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A statistical model predicting high hepatocyte proliferation index and the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis.
    Azzaroli F; Colecchia A; Lodato F; Trerè D; Bacchi Reggiani ML; Festi D; Prati GM; Accogli E; Casanova S; Derenzini M; Roda E; Mazzella G
    Aliment Pharmacol Ther; 2006 Jul; 24(1):129-36. PubMed ID: 16803611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis C.
    Hézode C; Zafrani ES; Roudot-Thoraval F; Costentin C; Hessami A; Bouvier-Alias M; Medkour F; Pawlostky JM; Lotersztajn S; Mallat A
    Gastroenterology; 2008 Feb; 134(2):432-9. PubMed ID: 18242211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contributions to hepatic fibrosis in HIV-HCV coinfected and HCV monoinfected patients.
    Monto A; Kakar S; Dove LM; Bostrom A; Miller EL; Wright TL
    Am J Gastroenterol; 2006 Jul; 101(7):1509-15. PubMed ID: 16863554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C.
    Huang H; Shiffman ML; Cheung RC; Layden TJ; Friedman S; Abar OT; Yee L; Chokkalingam AP; Schrodi SJ; Chan J; Catanese JJ; Leong DU; Ross D; Hu X; Monto A; McAllister LB; Broder S; White T; Sninsky JJ; Wright TL
    Gastroenterology; 2006 May; 130(6):1679-87. PubMed ID: 16697732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.